Nanobiotix
NBTX
26.50
-0.82
-2.98%
Nanobiotix
US · NBTX
#3096 by market cap
Listed 2020
26.50
-0.82
-2.98%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 2 analysts
Buy
Avg price target 64.00 +141.5%
Price target rangecurrent 26.50
Low64.00
Avg64.00
High64.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (9)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | TD Cowen | -- | Buy | -- |
| 2026-09-25 | Guggenheim | -- | Buy | 64.00 |
| 2026-09-15 | Guggenheim | -- | Buy | 64.00 |
| 2026-05-05 | Guggenheim | -- | Buy | 36.00 |
| 2026-04-02 | Guggenheim | -- | Buy | 36.00 |
| 2026-04-01 | TD Cowen | -- | Buy | -- |
| 2026-04-01 | Leerink Partners | -- | Buy | 37.00 |
| 2026-03-12 | TD Cowen | -- | Buy | -- |
| 2026-02-06 | TD Cowen | -- | Buy | -- |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Actual move |
|---|---|---|---|
| 2025/Q4 | 2026-03-31 | After close | +10.37% |
| 2024/Q4 | 2025-04-02 | -- | -0.59% |
| 2024/Q1 | 2024-05-22 | -- | +6.27% |
| 2023/Q4 | 2024-04-24 | -- | +0.17% |
| 2023/Q3 | 2023-11-13 | After close | -1.03% |
| 2023/Q2 | 2023-09-26 | After close | -1.52% |
| 2022/Q4 | 2023-04-24 | After close | -39.95% |
| 2022/Q3 | 2022-11-09 | -- | +0.00% |
| 2022/Q2 | 2022-09-28 | -- | -6.41% |
| 2022/Q1 | 2022-05-18 | -- | +6.59% |
| 2021/Q4 | 2022-03-30 | -- | +3.91% |
| 2021/Q2 | 2021-09-08 | -- | -2.55% |
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Nanobiotix discussion 0 comments